The event will present the company’s latest advancements in static, dynamic, and impact testing for the biomedical field, including live demonstrations on how to improve efficiency in the lab, ways to expand capabilities, and how to deliver more accurate and reliable test results. Seating is limited.
NAM President and CEO Jay Timmons released the following statement after the announcement of new U.S. tariffs on China and Chinese retaliatory tariffs on the United States.